{
    "pmcid": "11140111",
    "qa_pairs": {
        "How do nanobodies enhance their therapeutic efficacy when engineered for SARS-CoV-2 treatment?": [
            "Nanobodies can be engineered into multivalent formats or fused with Fc domains.",
            "Nanobodies are engineered to increase their molecular weight significantly.",
            "Nanobodies are engineered to decrease their solubility for longer circulation.",
            "Nanobodies are engineered to target only a single viral variant."
        ],
        "What is a notable feature of the CDR3 region in nanobodies that enhances their binding capabilities?": [
            "The CDR3 region is particularly long and flexible, allowing access to cryptic epitopes.",
            "The CDR3 region is short and rigid, providing strong binding to exposed epitopes.",
            "The CDR3 region is highly hydrophobic, enhancing membrane penetration.",
            "The CDR3 region is highly charged, facilitating electrostatic interactions."
        ],
        "What is the primary origin of nanobodies used in the treatment of microbial infections?": [
            "Nanobodies are derived from heavy-chain-only antibodies found in camelids like llamas and camels.",
            "Nanobodies are derived from conventional antibodies found in humans.",
            "Nanobodies are derived from light-chain-only antibodies found in rodents.",
            "Nanobodies are derived from synthetic peptides designed in laboratories."
        ],
        "Which nanobody was isolated from an alpaca and targets the RBD of the spike protein in both its 'up' and 'down' conformations?": [
            "Ty1",
            "H11-D4",
            "H11-H4",
            "Nb11\u201359"
        ],
        "Which specific region of the SARS-CoV-2 virus do nanobodies target to prevent viral entry?": [
            "Nanobodies target the receptor-binding domain (RBD) of the spike protein.",
            "Nanobodies target the nucleocapsid protein of the virus.",
            "Nanobodies target the membrane protein of the virus.",
            "Nanobodies target the envelope protein of the virus."
        ]
    }
}